Poul Manniche

Poul Manniche has a diverse work experience spanning several industries, with a focus on quality assurance and clinical research. Poul currently holds the position of VP of QA at Hansa Biopharma since January 2021. Prior to this, they served as the Head of Quality Assurance at Orphazyme A/S from March 2018 to January 2021. Poul also worked at Ferring Pharmaceuticals as the Director of Corporate Quality Audits from October 2011 to February 2018. Before that, they were the VP of Quality Management at Cyncron A/S from May 2009 to September 2011. Poul's experience in clinical research includes roles such as Clinical Project Leader at Neurosearch from August 2007 to April 2009, Clinical Operations Manager at Maxygen from May 2006 to July 2007, and Clinical Research Manager at Zealand Pharma A/S from May 2004 to May 2006. Poul started their career at GlaxoWellcome and Novo Nordisk A/S, where they held positions as a Clinical Research Manager and CQA Manager, respectively.

Poul Manniche obtained their MSc degree from the Faculty of Pharmaceutical Sciences at the University of Copenhagen, where they studied from 1974 to 1980. The field of study during this period was not specified.